// App-Quantinova.ai

37 EP620 : Liraglutide improves surfactant protein-B production and reduces right ventricular hypertrophy in a rat model of intersitial pulmonary fibrosis

Researchers

Presenter

  • Marina Romani Perez

Principal Investigators

  • Veronica Outeirino Iglesias

  • Yolanda Diz Chaves

  • Maria Gonzalez Nunez

  • Houcine Dab

  • Lucas Gonzalez Matias

  • Federico Mallo Ferrer

  • Eva Maria

  • Vigo Gago

Medical Centers

  • Nutrineuro, University of Bordeaux, INRA, Bordeaux, Aquitaine, France

  • Higher Institute of Applied Biology Medenine (ISBAM), University of Gabes, Medenine, Tunisia

  • Faculty of Biology. University of Vigo, Vigo (Pontevedra), Spain

  • Group of Endocrinology and Neurophysiology, Biomedical Research Center (CINBIO), University of Vigo, Vigo, Pontevedra, Spain

Locations

  • France

  • Spain

  • Tunisia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • Connective tissue growth factor

  • Surfactant Protein B

  • Transcription termination factor 1

Drug/Treatment

  • Streptozotocin

  • Liraglutide

  • Bleomycin

  • Intranasal glucagon

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved